Related Experiment Video
Updated: Apr 26, 2026
06:38
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.0K
Adjuvant therapy for renal cell carcinoma
1Medical Oncology Department, University Hospital La Paz - IdiPAZ, Madrid, Spain.
Clinical Genitourinary Cancer
|July 23, 2014
Summary
Adjuvant therapies for advanced kidney cancer show limited benefit, despite advancements in targeted treatments. Ongoing clinical trials are investigating new options for patients at high risk of relapse.
Area of Science:
- Oncology
- Nephrology
- Pharmacology
Background:
- Recent U.S. Food and Drug Administration approvals of targeted therapies have improved outcomes for advanced renal cell carcinoma.
- Despite progress in advanced disease, adjuvant therapies have not consistently shown clear benefits in preventing kidney cancer recurrence.
Purpose of the Study:
- To review current data on adjuvant therapy for kidney cancer.
- To summarize ongoing clinical trials for high-risk kidney cancer patients.
Main Methods:
- Review of available data on adjuvant treatments for renal cell carcinoma.
- Analysis of ongoing clinical trials in the adjuvant setting.
Main Results:
- Targeted therapies have improved progression-free survival and quality of life in advanced renal cell carcinoma.
- Adjuvant immune, hormonal, or targeted therapies have not yet demonstrated a clear benefit in preventing relapse.
Conclusions:
- The role of adjuvant therapy in kidney cancer remains an area of active investigation.
- Clinical trials are crucial for evaluating new adjuvant treatment strategies for patients at high risk of recurrence.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
02:49Cancer Therapies
8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.8K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
557
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
557
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K